Pharmaceutical Regulation and Product Liability
Below are selected materials from this conference, held under the auspices of the Institute's Product Liability Forum.
2 Recent Developments in US Pharmaceutical Regulation: Update on FDA Physician Labeling Rule
Paula M Stannard, Acting General Counsel, US Department of Health & Human Services
3 The Importance of Dialogue Between Regulators
Professor Vincenzo Salvatore, Head of Legal, European Medicines Agency (EMEA)
4 The Changing Shape of Pharmaceutical Risk
Dr Peter Feldschreiber, Medicines and Healthcare Products Regulatory Agency (MHRA)
5 The Fiancial Impact of Pharmaceutical Regulation and Litigation
Andrew Baum, Managing Director, Co-head European Pharmaceutical Research, Morgan Stanley
Ina Brock & Joe Cyr, Lovells
7 European Trends in Pharmaceutical Litigation
Dr Duncan Fairgrieve (British Institute of International and Comparative Law), Stefan Lenze (British Institute of International and Comparative Law/Lovells) & Prof Marco Bona (UniversitÃÂ Bocconi di Milano)
8 Liability Arising from Clinical Trials
Leigh-Ann Mulcahy, 4 New Square
Please note: this material is for reference only, and not to be cited without the authors' permission. If you have any difficulties accessing this material, please contact the Institute.
